Author:
Tan Shing Cheng,Lim Poh Ying,Fang Jie,Mokhtar Mira Farzana Mohamad,Hanif Ezanee Azlina Mohamad,Jamal Rahman
Abstract
AbstractNumerous studies have investigated the association of MIR499A rs3746444 polymorphism with breast cancer susceptibility, but the results have been inconsistent. In this work, we performed a meta-analysis to obtain a more reliable estimate of the association between the polymorphism and susceptibility to breast cancer. A comprehensive literature search was conducted on PubMed, Scopus, Web of Science (WoS), China National Knowledge Infrastructure (CNKI), VIP and Wanfang databases up to January 2020. A total of 14 studies involving 6,797 cases and 8,534 controls were included for analysis under five genetic models: homozygous (GG vs. AA), heterozygous (AG vs. AA), dominant (AG + GG vs. AA), recessive (GG vs. AA + AG) and allele (G vs. A). A statistically significant association was observed between the polymorphism and an increased breast cancer susceptibility under all genetic models (homozygous, OR = 1.33, 95% CI = 1.03–1.71, P = 0.03; heterozygous, OR = 1.08, 95% CI = 1.00–1.16, P = 0.04; dominant, OR = 1.15, 95% CI = 1.02–1.30; P = 0.03; recessive, OR = 1.35, 95% CI = 1.06–1.72, P = 0.01; allele, OR = 1.12, 95% CI = 1.00–1.26, P = 0.04). Subgroup analysis based on ethnicity suggested that significant association was present only among Asians, but not Caucasians. In conclusion, MIR499A rs3746444 polymorphism was significantly associated with breast cancer susceptibility among Asians, suggesting its potential use as a genetic risk marker in this population.
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 68, 394–424 (2018).
2. Nelson, H. D. et al. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: systematic review to update the U.S. Preventive Services Task Force Recommendation. (Agency for Healthcare Research and Quality (US), 2013).
3. Lippi, G., Mattiuzzi, C. & Montagnana, M. BRCA population screening for predicting breast cancer: for or against? Ann. Transl. Med. 5, 275–275 (2017).
4. Wendt, C. & Margolin, S. Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer. Acta Oncol 58, 135–146 (2019).
5. Cuzick, J., Brentnall, A. & Dowsett, M. SNPs for breast cancer risk assessment. Oncotarget 8, 99211–99212 (2017).